Advertisement
Loading...

Athenex, Inc.

ATNXNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.20
$0.00(0.00%)
U.S. Market opens in 28h 27m

Athenex, Inc. Fundamental Analysis

Athenex, Inc. (ATNX) shows moderate financial fundamentals with a PE ratio of -0.01, profit margin of -96.26%, and ROE of 21.51%. The company generates $0.2B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE21.51%
Cash Position2761.86%
PEG Ratio-0.00

Areas of Concern

Operating Margin-68.02%
We analyze ATNX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 25.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
25.8/100

We analyze ATNX's fundamental strength across five key dimensions:

Efficiency Score

Weak

ATNX struggles to generate sufficient returns from assets.

ROA > 10%
-48.50%

Valuation Score

Excellent

ATNX trades at attractive valuation levels.

PE < 25
-0.01
PEG Ratio < 2
-0.00

Growth Score

Weak

ATNX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ATNX maintains a strong and stable balance sheet.

Debt/Equity < 1
-6.51
Current Ratio > 1
1.09

Profitability Score

Weak

ATNX struggles to sustain strong margins.

ROE > 15%
21.51%
Net Margin ≥ 15%
-96.26%
Positive Free Cash Flow
No

Key Financial Metrics

Is ATNX Expensive or Cheap?

P/E Ratio

ATNX trades at -0.01 times earnings. This suggests potential undervaluation.

-0.01

PEG Ratio

When adjusting for growth, ATNX's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Athenex, Inc. at -0.20 times its book value. This may indicate undervaluation.

-0.20

EV/EBITDA

Enterprise value stands at 0.06 times EBITDA. This is generally considered low.

0.06

How Well Does ATNX Make Money?

Net Profit Margin

For every $100 in sales, Athenex, Inc. keeps $-96.26 as profit after all expenses.

-96.26%

Operating Margin

Core operations generate -68.02 in profit for every $100 in revenue, before interest and taxes.

-68.02%

ROE

Management delivers $21.51 in profit for every $100 of shareholder equity.

21.51%

ROA

Athenex, Inc. generates $-48.50 in profit for every $100 in assets, demonstrating efficient asset deployment.

-48.50%

Following the Money - Real Cash Generation

Operating Cash Flow

Athenex, Inc. generates limited operating cash flow of $-131.77M, signaling weaker underlying cash strength.

$-131.77M

Free Cash Flow

Athenex, Inc. generates weak or negative free cash flow of $-135.39M, restricting financial flexibility.

$-135.39M

FCF Per Share

Each share generates $-11.78 in free cash annually.

$-11.78

FCF Yield

ATNX converts -33.03% of its market value into free cash.

-33.03%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.01

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.20

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-6.51

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.09

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.22

vs 25 benchmark

ROA

Return on assets percentage

-0.49

vs 25 benchmark

ROCE

Return on capital employed

-0.78

vs 25 benchmark

How ATNX Stacks Against Its Sector Peers

MetricATNX ValueSector AveragePerformance
P/E Ratio-0.0128.62 Better (Cheaper)
ROE21.51%783.00% Weak
Net Margin-96.26%-48181.00% (disorted) Weak
Debt/Equity-6.510.39 Strong (Low Leverage)
Current Ratio1.094.12 Neutral
ROA-48.50%-21914.00% (disorted) Weak

ATNX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Athenex, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ